Sangamo Therapeutics, Inc. (SGMO)

0.4431 0.00 (0.00%) USD  |  NASDAQ  |  Dec 16, 13:26
More

Sangamo Therapeutics Cash and Short Term Investments (Quarterly): 30.53M for Sept. 30, 2025

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for SGMO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Arcturus Therapeutics Holdings, Inc. 235.36M
Agenus, Inc. 3.458M
AIM ImmunoTech, Inc. 2.409M
Protalix Biotherapeutics, Inc. 29.37M
Armata Pharmaceuticals, Inc. 14.76M